ArticleFrontiers in pharmacology2025

Application of nafamostat mesylate in 5 cases of extracorporeal carbon dioxide removal combined with continuous renal replacement therapy.

Ma Xiaobo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.